GKIM
IART icon

GW&K Investment Management’s Integra LifeSciences IART Stock Holding History

GW&K Investment Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-740
Closed -$17K – 1017
2024
Q4 		$17K Hold
740
– – ﹤0.01% 661
2024
Q3 		$13K Sell
740
-532,409
-100% -$12.3M ﹤0.01% 705
2024
Q2 		$15.5M Sell
533,149
-166,366
-24% -$4.93M 0.14% 219
2024
Q1 		$24.8M Buy
699,515
+5,962
+0.9% +$238K 0.22% 173
2023
Q4 		$30.2M Sell
693,553
-64,611
-9% -$2.54M 0.28% 148
2023
Q3 		$29M Buy
758,164
+4,678
+0.6% +$197K 0.29% 141
2023
Q2 		$31M Sell
753,486
-17,774
-2% -$855K 0.29% 143
2023
Q1 		$44.3M Buy
771,260
+6,622
+0.9% +$373K 0.43% 98
2022
Q4 		$42.9M Sell
764,638
-2,748
-0.4% -$140K 0.43% 97
2022
Q3 		$32.5M Sell
767,386
-4,214
-0.5% -$216K 0.36% 122
2022
Q2 		$41.7M Buy
771,600
+25,892
+3% +$1.55M 0.45% 92
2022
Q1 		$47.9M Buy
745,708
+28,922
+4% +$1.9M 0.43% 93
2021
Q4 		$48M Sell
716,786
-6,023
-0.8% -$407K 0.4% 102
2021
Q3 		$49.5M Sell
722,809
-3,873
-0.5% -$274K 0.44% 83
2021
Q2 		$49.6M Buy
726,682
+991
+0.1% +$70.1K 0.43% 85
2021
Q1 		$50.1M Buy
725,691
+99,892
+16% +$6.77M 0.46% 76
2020
Q4 		$40.6M Buy
625,799
+1,697
+0.3% +$91.3K 0.43% 89
2020
Q3 		$29.5M Buy
624,102
+5,457
+0.9% +$260K 0.39% 106
2020
Q2 		$29.1M Sell
618,645
-18,222
-3% -$896K 0.41% 96
2020
Q1 		$28.4M Buy
636,867
+541,181
+566% +$28.4M 0.5% 72
2019
Q4 		$5.58M Buy
+95,686
New +$5.7M 0.07% 234

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GW&K Investment Management's IART Position: Q1 2025 in Review

GW&K Investment Management sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 740 shares — an estimated $17K sold.

GW&K Investment Management first reported a position in IART in Q4 2019 and held it in 21 quarters. The position peaked at $50.1M in Q1 2021. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

  • GW&K Investment Management reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
  • GW&K Investment Management sold 740 Integra LifeSciences shares in Q1 2025, an estimated $17K.
  • GW&K Investment Management first reported a position in Integra LifeSciences in Q4 2019 and held it in 21 quarters.
  • GW&K Investment Management's Integra LifeSciences position peaked at $50.1M in Q1 2021.
  • 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on GW&K Investment Management's 13F filing for Q1 2025, filed 5 May 2025.